Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Albert J. Chang"'
Autor:
Trudy C. Wu, Alan Lee, Robert Suh, Talia C. Oughourlian, Fereidoun Abtin, Mary Ann Hagio, Sang-June Park, Albert J. Chang, Drew Moghanaki
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 2, Pp 150-155 (2024)
Patients with primary tumor progression after stereotactic body radiation therapy (SBRT) for stage I non-small cell lung cancer (NSCLC) have a second chance at complete tumor eradication with salvage local therapies, including lung resection, repeat
Externí odkaz:
https://doaj.org/article/72650a1c8f0344838c617283a549a4ca
Autor:
Christina Phuong, Jason W. Chan, Lisa Ni, Phillip Wall, Osama Mohamad, Anthony C. Wong, I.-Chow Hsu, Albert J. Chang
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background To evaluate acute and late genitourinary and gastrointestinal toxicities and patient reported urinary and sexual function following accelerated, hypofractionated external beam radiotherapy to the prostate, seminal vesicles and pel
Externí odkaz:
https://doaj.org/article/5a9deeb61a3244b2831c7c2d854ae681
Autor:
Kevin Shee, MD, PhD, Claire M. de la Calle, MD, Albert J. Chang, MD, PhD, Anthony C. Wong, MD, PhD, Felix Y. Feng, MD, Alexander R. Gottschalk, MD, PhD, Peter R. Carroll, MD, MPH, Hao G. Nguyen, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 5, Pp 100941- (2022)
Background: Enzalutamide is an antiandrogen used to treat both metastatic and nonmetastatic prostate cancer. Here we present results from a phase 2 trial designed to determine the safety, tolerability, and efficacy of adding enzalutamide to standard
Externí odkaz:
https://doaj.org/article/ed25005708004bb9a4745b9b93ffa0b3
Autor:
Stephanie M. Yoon, Robert Suh, Fereidoun Abtin, Drew Moghanaki, Scott Genshaft, Mitchell Kamrava, Alexandra Drakaki, Sandy Liu, Puja Venkat, Alan Lee, Albert J. Chang
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background Centrally located lung tumors present treatment challenges given their proximity to mediastinal structures including the central airway, esophagus, major vessels, and heart. Therapeutic options can be limited for medically inopera
Externí odkaz:
https://doaj.org/article/774901fed6d54a3da825ceae436d7b82
Autor:
Palak Kundu, Eric Y. Lin, Stephanie M. Yoon, Neil R. Parikh, Dan Ruan, Amar U. Kishan, Alan Lee, Michael L. Steinberg, Albert J. Chang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPatients with prostate cancer treated with stereotactic body radiation therapy (SBRT) may experience gastrointestinal (GI) toxicity. The hydrogel may mitigate this toxicity by reducing the rectal radiation dose. The purpose of this study is
Externí odkaz:
https://doaj.org/article/90d5d521fb2c44f2bdcb642603024ad6
Publikováno v:
Pharmaceuticals, Vol 5, Iss 1, Pp 79-93 (2012)
The human epidermal growth factor receptor 2 (HER2/neu) is overexpressed in 20–30% of breast cancers and is associated with tumor growth, angiogenesis, and development of distant metastases. Trastuzumab, an anti-HER2 monoclonal antibody, is used fo
Externí odkaz:
https://doaj.org/article/90d229163f88483398bd8b0342f331f4
Autor:
Jessie R. Nedrow, Alexander G. White, Jalpa Modi, Kim Nguyen, Albert J. Chang, Carolyn J. Anderson
Publikováno v:
Molecular Imaging, Vol 13 (2014)
The bifunctional chelator and radiometal have been shown to have a direct effect on the pharmacokinetics of somatostatin receptor (SSTR)-targeted imaging agents. We evaluated three Y3-TATE analogues conjugated to NOTA-based chelators for radiolabelin
Externí odkaz:
https://doaj.org/article/6ca6cfacc1144711a9921f72ab763be8
Autor:
Sagar A. Patel, Brian Baumann, Jeff Michalski, Randall Brenneman, Bill Zheng, Hiram Gay, Daniel Ferraro, Simon A. Brown, Albert J. Chang, Peter J. Rossi, Benjamin W. Fischer-Valuck
Publikováno v:
Brachytherapy. 22:310-316
Autor:
Luca F. Valle, Tommy Jiang, Adam B. Weiner, Robert E. Reiter, Matthew B. Rettig, John Shen, Albert J. Chang, Nicholas G. Nickols, Michael L. Steinberg, Amar U. Kishan
Publikováno v:
Current Oncology Reports. 25:221-229
Autor:
Mark T. Corkum, Mark K. Buyyounouski, Albert J. Chang, Hans T. Chung, Peter Chung, Brett W. Cox, Juanita M. Crook, Brian J. Davis, Steven J. Frank, Ivan Henriquez, Eric M. Horwitz, Peter Hoskin, I-Chow Hsu, Mira Keyes, Martin T. King, Marisa A. Kollmeier, Daniel J. Krauss, Andrzej M. Kukielka, Gerard Morton, Peter F. Orio, Bradley R. Pieters, Louis Potters, Peter J. Rossi, Timothy N. Showalter, Abhishek A. Solanki, Daniel Song, Ben Vanneste, Eric Vigneault, Piotr A. Wojcieszek, Michael J. Zelefsky, Mitchell Kamrava
Publikováno v:
Radiotherapy and oncology, 184:109672. Elsevier Ireland Ltd
Radiotherapy and Oncology, 184:109672. Elsevier Ireland Ltd
Radiotherapy and Oncology, 184:109672. Elsevier Ireland Ltd
Background and Purpose: Local recurrences after previous radiotherapy (RT) are increasingly being identified in biochemically recurrent prostate cancer. Salvage prostate brachytherapy (BT) is an effective and well tolerated treatment option. We sough
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae21e4a6756492ceff8636cf551050d8
https://pure.amc.nl/en/publications/salvage-prostate-brachytherapy-in-radiorecurrent-prostate-cancer(10a618af-3823-438d-acb1-38b682c83559).html
https://pure.amc.nl/en/publications/salvage-prostate-brachytherapy-in-radiorecurrent-prostate-cancer(10a618af-3823-438d-acb1-38b682c83559).html